International Pharmaceutical Corridor: India to Gulf Initiate Dossier & Export Enquiry →

Better health,
without borders.

A premier partner for international pharmaceutical trade, WHO-GMP contract manufacturing coordination, and expedited regulatory CTD dossier support across the Gulf Cooperation Council (GCC) and global healthcare markets.

Elwont Mark Engineered around quality, regulatory rigor and long-term trust
Live Export Batch Feed • 47 Formulations
CODEMOLECULE / COMPOSITIONFORMCOMPLIANCE
EW-001Paracetamol 500mgTabletUSP / BP / IP
EW-002Amoxicillin 250mgCapsuleWHO-GMP
EW-003Metformin 500mgTabletSFDA Ready
EW-004Omeprazole 20mgCapsuleCTD Dossier
Portfolio catalogue: 4 of 47 molecules WHO-GMP • ISO 9001
Scroll to discover
47+
Commercial Formulations
Oral solids, liquids & injectables
6 Markets
Active Gulf Trade Corridors
KSA, UAE, Oman, Qatar, Kuwait, Bahrain
100%
Regulatory Compliance
WHO-GMP & SFDA audit standard
24h
Dossier Turnaround
Fast-track partner technical response

Healthcare moves forward when trust travels across borders. Build an international partnership →

Elwont Pharmaceutical is an India-based leader focused on international pharmaceutical trade, end-to-end export logistics, and dependable healthcare solutions.

We bring a considered, client-first approach to formulation access, contract manufacturing coordination, and regulatory compliance. Every collaboration is shaped around the exacting requirements of destination ministries of health, regional distribution partners, and a shared commitment to patient health.

Our ambition is to establish enduring alliances with licensed importers, hospital networks, and pharmaceutical distributors across the Gulf Cooperation Council and global growth markets.

01

Quality in every detail

Disciplined molecule selection and analytical coordination, rigorously verified against USP/BP/IP standards and pharmacopeial monographs.

02

Partnerships that endure

Transparent communication, predictable dispatch schedules, and a multi-year outlook for regional distribution channels.

03

Global by design

Export-centric thinking, refrigerated cold-chain management, and documentation precision that streamline customs and ministerial approvals.

Commercial formulation portfolio.

A growing catalogue of high-demand therapeutic molecules ready for international export and regulatory filing.

10 of 10 products
CODE MOLECULE / COMPOSITION DOSAGE FORM THERAPEUTIC CLASS DOSSIER ACTION
All formulations manufactured in WHO-GMP certified facilities with full CTD/ACTD dossier modules. Need a custom strength or combination? Request tailored dossier →
Active Therapeutic Groups: Analgesics Antibiotics & Antimicrobials Antidiabetics Gastrointestinal Cardiovascular Neurology
01 Market Requirement & Gap Analysis Comprehensive review of target health authority regulations (SFDA Saudi Arabia, MOH UAE, EDA Egypt, MOH Oman) and pharmacopeial prerequisites.
02 Dossier Assembly & Stability Testing Compilation of Modules 1 through 5, real-time and accelerated stability study records (Zone IVb: 30°C/75% RH), and Certificates of Pharmaceutical Products (COPP).
03 Registration & Commercial Clearance Coordinated support with your local marketing authorization holder (MAH) and commercial logistics desk to secure prompt import clearances.

Confidence begins with regulatory clarity.

Every sovereign market mandates specific compliance frameworks. We provide pharmaceutical distributors and importers with the documentation velocity required to transform therapeutic opportunities into authorized commercial distribution.

Discuss Regulatory Support Scope varies according to jurisdiction and product schedule. Final market authorization is determined by statutory health ministries.

Capability, engineered around patient care.

Our third-party manufacturing alliances are coordinated with unyielding focus on rigorous analytical testing, validated sterile processes, and repeatable batch consistency.

Coordination protocols are calibrated around verified distributor commitments. Production site accreditations, dosage form capabilities (oral solids, liquids, sterile injectables), and volume throughput are disclosed in detail against verified requirements.

Discuss manufacturing specifications →
Quality
by design
ELWONT • WHO-GMP
Strategic Trade Artery • India to GCC Corridor

Closer to the markets that matter.

Direct temperature-validated pharmaceutical air and maritime shipping routes connecting WHO-GMP manufacturing clusters in India to licensed healthcare distributors across the Gulf.

Active Corridors: 6 Strategic GCC Markets • 100% GDP & Cold-Chain Validated
🇸🇦

Saudi Arabia

SFDA Regulatory Clearance
Air Cargo Port:RUH (Riyadh) / JED (Jeddah) • 3–4 Days
Ocean Port:Jeddah Islamic Port / Dammam • 12 Days
Cold-Chain Spec:2°C–8°C / 15°C–25°C Validated
Dossier Protocol:ACTD / CTD Zone IVb Modules Ready
32°N (Levant / Northern Gulf) 24°N (Tropic of Cancer / Riyadh) 15°N (Arabian Sea Corridor) 46°E 62°E 78°E (Mumbai Export Gateway) ARABIAN SEA PHARMA LANE PERSIAN GULF RED SEA GULF OF OMAN INDIA (Mumbai / JNPT Gateway) Riyadh (KSA • SFDA) Jeddah Islamic Port Dubai / Jebel Ali (UAE) Muscat / Sohar (Oman) Doha (Qatar) Manama (Bahrain) Kuwait City (Kuwait)
Elwont Orb

Bring your ambition to international healthcare.

We are building an agile, globally minded team of international trade managers, regulatory pharmacists, and quality assurance specialists. Expressions of interest are welcome.

Connect with Talent Team

Good partnerships start with a conversation.

Share your target country, therapeutic category, or commercial volume requirements. Our international trade desk responds within 24 business hours.

Direct Business Enquiries We welcome licensed importers, regional distributors, and hospital procurement partners.

Your enquiry is routed directly to our international business development and regulatory compliance desk.